Blog · Market & methods

Healthcare AI spending is surging — methods quality still decides who scales

Vendor forecasts put U.S. healthcare AI on a steep growth curve. Parallel industry reporting describes stubborn pilot-to-production failure. The gap is often methodological—not a lack of GPUs.

Market growth (treat as forecast, not gospel)

Commercial market reports (e.g., Research and Markets and peers) have projected U.S. AI-in-healthcare revenue on the order of tens of billions by the early 2030s, with high double-digit CAGRs from mid-2020s baselines. Exact dollar figures vary by definition of “AI in healthcare.” Cite the primary report you use and note the scope.

Example report family: Research and Markets — United States AI in Healthcare Market (search current edition on researchandmarkets.com).

The quality / scaling gap

Industry analyses commonly report that a large share of healthcare AI pilots never reach sustained production (figures like “~90% fail to scale” appear in vendor/consulting pieces—verify the methodology of whichever source you cite). Separately, widely discussed MIT-associated coverage of enterprise generative AI pilots reported very high rates of projects without measurable ROI—that finding is about genAI pilots broadly, not EHR risk models specifically.

Common technical failure modes for predictive clinical ML:

How the EHR Risk Framework helps

Sources

Try the workbench

How it works A–Z Live demo Quickstart GitHub

Free demo server — it may be slow. Check it with a small amount of data. For larger workloads or freer experimentation, run locally or on your own server. Open live demo

Feedback: support@larucare.com · Cite: DOI & CITATION.cff